CompoAtlas

Valdispert mélatonine végétale 100% naturelle 1mg

Food supplement declared in France, declaration No 2020-6-178, decision dated 4 June 2020

Valdispert mélatonine végétale 100% naturelle 1mg, from VEMEDIA CONSUMER HEALTH FRANCE, is a food supplement declared in France. Status: declared in France, may be marketed. Main ingredients: Medicago sativa 84 mg per day, Oryza sativa 9 mg per day, Chlorella vulgaris 7 mg per day. 1 rule of use applies to its ingredients (limits and warnings).

Brand
Valdispert
Food business operator placing the product on the market
VEMEDIA CONSUMER HEALTH FRANCE
Status
Declared in France, may be marketed: the authorities did not object to the declaration (this is neither an authorisation nor a safety assessment)
Form
Tablet
Daily dose
1 comprimé par jour
Directions for use
Prendre 1 comprimé le soir 30 minutes avant le coucher.
Not recommended (according to the manufacturer)
Breastfeeding women, History of breast cancer, Children (under 12), Pregnant women
Objectives stated by the manufacturer (these are not authorised claims)
Sleep

Declaration 305684, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 15 November 2026.

Declared composition

Plants

PlantPartPreparationPer day
Medicago sativa L.LeafDry aqueous extract84 mg
Oryza sativa L.SeedDry aqueous extract9 mg
Chlorella vulgaris BeijerinckWhole plantDry aqueous extract7 mg

Additives

E953, E460, E463, E470b

List from the declaration, administrative decision dated (Compl'Alim, food supplement declarations (France)).

Photograph the packaging

Label warnings

Précautions d’utilisation : L’utilisation de ce complément alimentaire n’est pas recommandée pour les enfants de moins 12 ans, les femmes enceintes ou allaitantes et les personnes immunodéprimées. L’utilisation est déconseillée chez les femmes ayant des antécédents personnels ou familiaux de cancer du sein. Ne pas dépasser la dose journalière recommandée. Tenir hors de portée des enfants. Demandez conseil à un professionnel de santé

Regulatory points

This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.

Official warnings (Health Canada)

Health Canada publishes warnings on these ingredients:

  • Medicago sativa L.
    Read the warning, when it applies and the studies cited

    ALFALFA - MEDICAGO SATIVA

    Route of administration: Oral

    Cautions and warnings

    Applies to products providing more than 900 mg of Alfalfa dried herb top/leaf, per day.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking blood thinners, birth control medication or hormone therapy (Brinker 2010; Barnes et al. 2007; Boon and Smith 2004).

    Sources cited by Health Canada (3)
    • Barnes J, Anderson LA, Philipson JD. Herbal Medicines, 3rd edition. London (UK): Pharmaceutical Press; 2007.
    • Boon H, Smith MJ. The Complete Natural Medicine Guide to the 50 Most Common Medicinal Herbs, 2nd edition. Toronto (ON): Robert Rose Inc; 2004.
    • Brinker F. Herb Contraindications and Drug Interactions, 4e édition. Sandy (OR): Eclectic Medical Publications; 2010.

    Contraindications

    Condition of application: All products.

    Do not use if you are pregnant or breastfeeding (Brinker 2010; Barnes et al. 2007; Boon and Smith 2004).

    Sources cited by Health Canada (3)
    • Barnes J, Anderson LA, Philipson JD. Herbal Medicines, 3rd edition. London (UK): Pharmaceutical Press; 2007.
    • Boon H, Smith MJ. The Complete Natural Medicine Guide to the 50 Most Common Medicinal Herbs, 2nd edition. Toronto (ON): Robert Rose Inc; 2004.
    • Brinker F. Herb Contraindications and Drug Interactions, 4e édition. Sandy (OR): Eclectic Medical Publications; 2010.

    Applies to products providing more than 900 mg of Alfalfa dried herb top/leaf, per day.

    Do not use if you have a history of systemic lupus erythematosus (Brinker 2010; Barnes et al. 2007; Boon and Smith 2004).

    Sources cited by Health Canada (3)
    • Barnes J, Anderson LA, Philipson JD. Herbal Medicines, 3rd edition. London (UK): Pharmaceutical Press; 2007.
    • Boon H, Smith MJ. The Complete Natural Medicine Guide to the 50 Most Common Medicinal Herbs, 2nd edition. Toronto (ON): Robert Rose Inc; 2004.
    • Brinker F. Herb Contraindications and Drug Interactions, 4e édition. Sandy (OR): Eclectic Medical Publications; 2010.

    Health Canada monograph dated 29 November 2024

  • Chlorella vulgaris Beijerinck
    Read the warning, when it applies and the studies cited

    CHLORELLA - CHLORELLA VULGARIS

    Route of administration: Oral

    Cautions and warnings

    Condition of application: All products.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding.

    Applies to products providing 250 mg or more of chlorella per day or 6 µg or more vitamin K per day.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking blood thinners (Ohkawa et al. 1995; NNHPD Multi-vitamin/mineral supplements monograph).

    Sources cited by Health Canada (1)
    • Ohkawa S, Yoneda Y, Ohsumi Y, Tabuchi M. Warfarin therapy and chlorella. Rinsho Shinkeigaku 1995;35(7):806-807. PubMed Case report

    Applies to products containing chlorella enriched with selenium and providing more than 70 µg of selenium per day.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have a history of non-melanoma skin cancer (Doucha et al. 2009; NNHPD Multi-vitamin/mineral supplements monograph).

    Sources cited by Health Canada (1)
    • Doucha J, Livansky K, Kotrbacek V, Zachleder V. Production of Chlorella biomass enriched by selenium and its use in animal nutrition: a review. Applied Microbiology and Biotechnology 2009;83(6):1001-1008. PubMed Review article

    Known adverse reactions

    Stop use if hypersensitivity/allergy occurs (Tiberg et al. 1995).

    Sources cited by Health Canada (1)
    • Tiberg E, Dreborg S, Bjorksten B. Allergy to green algae (Chlorella) among children. Journal of Allergy and Clinical Immunology 1995;96(2):257-259. PubMed

    Health Canada monograph dated 27 June 2025

They concern the ingredient, not this product or its dose. They do not replace medical advice.

Brand : Valdispert

Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.

Cite this page: CompoAtlas, “Valdispert mélatonine végétale 100% naturelle 1mg: composition and regulation”, https://compoatlas.com/en/supplements/products/305684-valdispert-melatonine-vegetale-100-naturelle-1mg, updated 15 November 2026.

List recorded in 2020. Photograph the packaging to check whether it has changed.

Enter to analyse, Shift+Enter for a new line